Literature DB >> 11503955

The role of apoptosis in the pathogenesis of the myelodysplastic syndromes.

Jane E Parker1, Ghulam J Mufti2.   

Abstract

The paradoxical occurrence of peripheral cytopenias despite a normo/hypercellular marrow in myelodysplastic syndromes (MDS) has been attributed to excessive intramedullary hematopoietic cell apoptosis. It has also been postulated that abrogation of programmed cell death (PCD) may underlie MDS transformation to acute myeloid leukemia (AML). Despite overwhelming evidence for a role of aberrant apoptosis in myelodysplasia, the molecular mechanisms responsible for such changes have not been elucidated. This paper summarizes current evidence implicating a role for altered PCD in MDS and outlines potential cellular mechanisms whereby hematopoietic progenitor cell apoptosis may be dysregulated.

Entities:  

Mesh:

Year:  2001        PMID: 11503955     DOI: 10.1007/BF02994003

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  148 in total

1.  BCL-2 immunoreactivity increases with severity of CIN: a study of normal cervical epithelia, CIN, and cervical carcinoma.

Authors:  B Ter Harmsel; F Smedts; J Kuijpers; M Jeunink; B Trimbos; F Ramaekers
Journal:  J Pathol       Date:  1996-05       Impact factor: 7.996

2.  Fas ligand-induced apoptosis as a mechanism of immune privilege.

Authors:  T S Griffith; T Brunner; S M Fletcher; D R Green; T A Ferguson
Journal:  Science       Date:  1995-11-17       Impact factor: 47.728

3.  Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c.

Authors:  X Liu; C N Kim; J Yang; R Jemmerson; X Wang
Journal:  Cell       Date:  1996-07-12       Impact factor: 41.582

4.  Excessive proliferation matched by excessive apoptosis in myelodysplastic syndromes: the cause-effect relationship.

Authors:  A Raza; S Alvi; R Z Borok; L Span; A Parcharidou; D Alston; S Rifkin; E Robin; R Shah; S A Gregory
Journal:  Leuk Lymphoma       Date:  1997-09

5.  Inhibition of death receptor signals by cellular FLIP.

Authors:  M Irmler; M Thome; M Hahne; P Schneider; K Hofmann; V Steiner; J L Bodmer; M Schröter; K Burns; C Mattmann; D Rimoldi; L E French; J Tschopp
Journal:  Nature       Date:  1997-07-10       Impact factor: 49.962

6.  Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors.

Authors:  J P Sheridan; S A Marsters; R M Pitti; A Gurney; M Skubatch; D Baldwin; L Ramakrishnan; C L Gray; K Baker; W I Wood; A D Goddard; P Godowski; A Ashkenazi
Journal:  Science       Date:  1997-08-08       Impact factor: 47.728

7.  Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis.

Authors:  S M Laster; J G Wood; L R Gooding
Journal:  J Immunol       Date:  1988-10-15       Impact factor: 5.422

8.  Indication of an involvement of interleukin-1 beta converting enzyme-like protease in intramedullary apoptotic cell death in the bone marrow of patients with myelodysplastic syndromes.

Authors:  S D Mundle; P Venugopal; J D Cartlidge; D V Pandav; L Broady-Robinson; S Gezer; E L Robin; S R Rifkin; M Klein; D E Alston; B M Hernandez; D Rosi; S Alvi; V T Shetty; S A Gregory; A Raza
Journal:  Blood       Date:  1996-10-01       Impact factor: 22.113

Review 9.  Apoptosis and its role in the myelodysplastic syndromes: implications for disease natural history and treatment.

Authors:  P L Greenberg
Journal:  Leuk Res       Date:  1998-12       Impact factor: 3.156

10.  Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity.

Authors:  V Goossens; J Grooten; K De Vos; W Fiers
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

View more
  8 in total

1.  Stress-induced hematopoietic failure in the absence of immediate early response gene X-1 (IEX-1, IER3).

Authors:  Haley Ramsey; Qi Zhang; Diane E Brown; David P Steensma; Charles P Lin; Mei X Wu
Journal:  Haematologica       Date:  2013-09-20       Impact factor: 9.941

2.  Over-expression of miR-196b-5p is significantly associated with the progression of myelodysplastic syndrome.

Authors:  Jing Wen; Ying Huang; Hongying Li; Xupai Zhang; Peng Cheng; Donghong Deng; Zhigang Peng; Jun Luo; Weihua Zhao; Yongrong Lai; Zhenfang Liu
Journal:  Int J Hematol       Date:  2017-02-21       Impact factor: 2.490

3.  Noninvasive imaging of cell death using an Hsp90 ligand.

Authors:  Danielle Park; Anthony S Don; Tania Massamiri; Amol Karwa; Beth Warner; Jan MacDonald; Christine Hemenway; Arati Naik; Kah-Tiong Kuan; Pierre J Dilda; Jason W H Wong; Kevin Camphausen; Lori Chinen; Mary Dyszlewski; Philip J Hogg
Journal:  J Am Chem Soc       Date:  2011-02-15       Impact factor: 15.419

4.  Mito-protective autophagy is impaired in erythroid cells of aged mtDNA-mutator mice.

Authors:  XiuJie Li-Harms; Sandra Milasta; John Lynch; Christopher Wright; Aashish Joshi; Rekha Iyengar; Geoffrey Neale; Xi Wang; Yong-Dong Wang; Tomas A Prolla; James E Thompson; Joseph T Opferman; Douglas R Green; John Schuetz; Mondira Kundu
Journal:  Blood       Date:  2014-11-19       Impact factor: 22.113

Review 5.  Pathogenesis, classification, and treatment of myelodysplastic syndromes (MDS).

Authors:  Peter Valent; Friedrich Wimazal; Ilse Schwarzinger; Wolfgang R Sperr; Klaus Geissler
Journal:  Wien Klin Wochenschr       Date:  2003-08-14       Impact factor: 1.704

6.  Impaired differentiation and apoptosis of hematopoietic precursors in a mouse model of myelodysplastic syndrome.

Authors:  Chul Won Choi; Yang Jo Chung; Christopher Slape; Peter D Aplan
Journal:  Haematologica       Date:  2008-07-04       Impact factor: 9.941

7.  Innovative analyses support a role for DNA damage and an aberrant cell cycle in myelodysplastic syndrome pathogenesis.

Authors:  David R Head; James W Jacobberger; Claudio Mosse; Madan Jagasia; William Dupont; Stacey Goodman; Leanne Flye; Andrew Shinar; Sara McClintock-Treep; Greg Stelzer; Robert Briggs; Keith Shults
Journal:  Bone Marrow Res       Date:  2011-06-07

8.  Detailed analysis of clonal evolution and cytogenetic evolution patterns in patients with myelodysplastic syndromes (MDS) and related myeloid disorders.

Authors:  Julie Schanz; Naciye Cevik; Christa Fonatsch; Friederike Braulke; Katayoon Shirneshan; Ulrike Bacher; Detlef Haase
Journal:  Blood Cancer J       Date:  2018-03-07       Impact factor: 11.037

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.